""	"Rank"	"NCT.Number"	"Title"	"Status"	"Study.Results"	"Conditions"	"Interventions"	"Phases"	"Study.Type"	"Locations"	"URL"
"8"	8	"NCT04445272"	"Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia"	"Recruiting"	"No Results Available"	"COVID-19"	"drug: tocilizumab"	"Phase 2"	"Interventional"	"Hospital Universitario de Cabueñes, Gijón, Asturias, Spain|Hospital Universitario Central Asturias, Oviedo, Asturias, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Sant Joan de Déu de Manresa, Manresa, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Hospital Universitario Marqués Valdecilla, Santander, Cantabria, Spain|Hospital Público General del Tomelloso, Tomelloso, Ciudad Real, Spain|Hospital Jerez de la Frontera, Jerez De La Frontera, Cádiz, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Islas Baleares, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Nuestra Señora del Prado, Talavera De La Reina, Toledo, Spain|Complejo Hospitalario Universitario de Albacete, Albacete, Spain|Hospital Infanta Cristina, Badajoz, Spain|Hospital Clínic i Provincial Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital General Universitario de Ciudad Real, Ciudad Real, Spain|Hospital San Pedro Alcántara, Cáceres, Spain|Hospital Universitario Dr. Josep Trueta, Gerona, Spain|Hospital Universitario Clínico San Cecilio, Granada, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Complexo Hospitalario Universitario de Ourense, Orense, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitario Virgen de la Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Hospital Universitari i Poliectenic La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain"	"https://ClinicalTrials.gov/show/NCT04445272"
"10"	10	"NCT04345445"	"Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression"	"Not yet recruiting"	"No Results Available"	"COVID-19"	"drug: tocilizumab|drug: methylprednisolone"	"Phase 3"	"Interventional"	"University Malaya Medical Centre, Kuala Lumpur, Malaysia"	"https://ClinicalTrials.gov/show/NCT04345445"
"69"	69	"NCT04317092"	"Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)"	"Recruiting"	"No Results Available"	"COVID-19 Pneumonia"	"drug: tocilizumab injection"	"Phase 2"	"Interventional"	"Azienda Ospedaliera \"SS. Antonio e Biagio e C. Arrigo\" (Dipartimento Internistico SSD Reumatologia), Alessandria, Italy|Ospedale di Busto Arsizio ASST Valle Olona (U.O.C. Malattie Infettive), Busto Arsizio, Italy|A.O.U. Policlinico V. Emanuele (U.O. di Malattie infettive, U.O. di Anestesia e Rianimazione, U.O. di Medicina d'Urgenza), Catania, Italy|AOE Cannizzaro di Catania (U.O. di Malattie Infettive, U.O. di Anestesia e Rianimazione, U.O., Catania, Italy|Ospedale Annunziata Azienda Ospedaliera di Cosenza (U.O.C. Malattie Infettive), Cosenza, Italy|ASST OVEST MILANESE presidi Legnano - Magenta, Magenta, Italy|Azienda Ospedaliero-Universitaria di Modena, Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione I), Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione II), Modena, Italy|A.O.U. di Modena (Dipartimento Medicine Specialistiche - Struttura Complessa Malattie Infettive), Modena, Italy|Dipartimento Medicine Specialistiche - Struttura Complessa Malattie dell'Apparato Respiratorio, Modena, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Oncologia), Naples, Italy|National Cancer Institute, Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Anestesia Rianimazione e terapia intensiva), Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Malattie Infettive ad indirizzo respiratorio), Naples, Italy|A.O. Ospedali Riuniti Marche Nord - Presidio Ospedaliero San Salvatore di Pesaro (UOC Pronto Soccorso e Medicina d'Urgenza), Pesaro, Italy|Denominazione: UOC di Medicina e Chirurgia d'Accettazione e d'Urgenza dell'Ospedale Santa Maria delle Grazie di Pozzuoli, Pozzuoli, Italy|Ospedale Santa Maria delle Croci, AUSL della Romagna (U.O. Anestesia e Rianimazione), Ravenna, Italy|Grande Ospedale Metropolitano, Reggio Calabria, Reggio Calabria, Italy|Ospedale Infermi, AUSL della Romagna (U.O. Malattie Infettive), Rimini, Italy|Policlinico Gemelli (U.O.C. Dipartimento Scienze di Laboratorio e Infettivologiche), Rome, Italy|ASST Sette Laghi (Dipartimento di Medicina Interna), Varese, Italy|ASST Sette Laghi (Dipartimento Emergenze ed Urgenze), Varese, Italy|ASST Sette Laghi (U.O.C. Anestesia e Rianimazione Neurochirurgica e Generale), Varese, Italy|ASST Sette Laghi (U.O.C. Malattie Infettive e Tropicali), Varese, Italy|A.O.U. Integrata di Verona (Dip. Malattie Infettive), Verona, Italy|Ospedale Magalini (U.O. Malattie Infettive), Villafranca Di Verona, Italy"	"https://ClinicalTrials.gov/show/NCT04317092"
"121"	121	"NCT04330638"	"Treatment of COVID-19 Patients With Anti-interleukin Drugs"	"Recruiting"	"No Results Available"	"COVID-19"	"other: usual care|drug: anakinra|drug: siltuximab|drug: tocilizumab"	"Phase 3"	"Interventional"	"AZ Sint-Jan Brugge, Brugge, Belgium|University Hospital Saint-Pierre, Brussels, Belgium|Erasmus University Hospital, Brussels, Belgium|University Hospital Saint-Luc, Brussels, Belgium|University Hospital Antwerp, Edegem, Belgium|Ziekenhuis Oost-Limurg, Genk, Belgium|AZ Sint-Lucas, Gent, Belgium|University Hospital Ghent, Gent, Belgium|Jessa ZH, Hasselt, Belgium|University Hospital Brussels, Jette, Belgium|CHU Tivoli, La Louvière, Belgium|CHR de la Citadelle, Liège, Belgium|University Hospital Liège, Liège, Belgium|Cliniques Saint-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium|AZ Delta, Roeselare, Belgium"	"https://ClinicalTrials.gov/show/NCT04330638"
"182"	182	"NCT04412772"	"A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS"	"Recruiting"	"No Results Available"	"COVID-19"	"drug: tocilizumab|drug: placebo"	"Phase 3"	"Interventional"	"Queen's Medical Center, Honolulu, Hawaii, United States"	"https://ClinicalTrials.gov/show/NCT04412772"
"205"	205	"NCT04331795"	"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis"	"Completed"	"No Results Available"	"COVID-19"	"drug: tocilizumab"	"Phase 2"	"Interventional"	"University of Chicago Medicine, Chicago, Illinois, United States"	"https://ClinicalTrials.gov/show/NCT04331795"
"213"	213	"NCT04377659"	"Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection"	"Recruiting"	"No Results Available"	"COVID-19"	"drug: tocilizumab"	"Phase 2"	"Interventional"	"Memorial Sloan Kettering Cancer Center, New York, New York, United States"	"https://ClinicalTrials.gov/show/NCT04377659"
"242"	242	"NCT04332094"	"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19"	"Recruiting"	"No Results Available"	"COVID-19"	"drug: tocilizumab|drug: hydroxychloroquine|drug: azithromycin"	"Phase 2"	"Interventional"	"Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"	"https://ClinicalTrials.gov/show/NCT04332094"
"278"	278	"NCT04346355"	"Efficacy of Early Administration of Tocilizumab in COVID-19 Patients"	"Terminated"	"No Results Available"	"COVID-19 Pneumonia"	"drug: tocilizumab"	"Phase 2"	"Interventional"	"Ospedale di Guastalla, Guastalla, RE, Italy|Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, RE, Italy|Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Policlinico Sant'Orsola Malpighi, Bologna, Italy|ASST Cremona, Cremona, Italy|Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy|Azienda Ospedaliero Universitaria Ferrara, Ferrara, Italy|Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|Ospedale Evangelico Internazionale di Genova, Genova, Italy|Azienda Sociosanitaria ASL 1 ,Imperia, Imperia, Italy|Azienda Sociosanitaria ASL 5 La Spezia, La Spezia, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|IRCCS Istituto Auxologico Italiano Milano, Milano, Italy|Azienda Ospedaliero-Universitaria \"Maggiore della Carità\" di Novara, Novara, Italy|Ospedali Riuniti Padova Sud - ULSS 6 Euganea, Padova, Italy|Azienda Ospedaliero-Universitaria Parma, Parma, Italy|Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|AO Ordine Mauriziano di Torino, Torino, Italy|ASST Bergamo Ovest -Treviglio, Treviglio, Italy|AULSS 2 Marca Trevigiana, Treviso, Italy|AULSS2 Marca Trevigiana - Ospedale Vittorio Veneto, Treviso, Italy|AULSS 3 Serenissima Ospedale \"Dell'Angelo\", Venezia, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy|IRCCS Sacro Cuore Don Calabria, Verona, Italy"	"https://ClinicalTrials.gov/show/NCT04346355"
"284"	284	"NCT04320615"	"A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia"	"Active, not recruiting"	"No Results Available"	"COVID-19 Pneumonia"	"drug: tocilizumab (tcz)|drug: placebo"	"Phase 3"	"Interventional"	"University of California San Diego, La Jolla, California, United States|eStudySite, La Mesa, California, United States|David Geffen School of Medicine UCLA, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Denver Health Medical Center, Denver, Colorado, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Ochsner Clinic Foundation, Baton Rouge, Louisiana, United States|Baystate Health System, Springfield, Massachusetts, United States|Mayo Clinic - PPDS, Rochester, Minnesota, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital/Rutgers, New Brunswick, New Jersey, United States|James J Peters Veterans Administration Medical Center - NAVREF, Bronx, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cleveland Clinic Foundation; Pulmonary, Allergy & Critical Care Medicine, Cleveland, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Ben Taub General Hospital - HCHD, Houston, Texas, United States|Intermountain Medical Group, Saint George, Utah, United States|Intermountain LDS Hospital, Salt Lake City, Utah, United States|Evergreen Health Infectious Disease, Kirkland, Washington, United States|Swedish Hospital Medical Center, Seattle, Washington, United States|Hamilton General Hospital; Pharmacy, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Clinical Research Institute of Montreal, Montreal, Quebec, Canada|Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense Universitetshospital, Odense C, Denmark|Sjællands Universitetshospital, Roskilde, Roskilde, Denmark|Centre Hospitalier Departemental de Vendee, La Roche Sur Yon, France|Centre Hospitalier et Universitaire de Limoges, Limoges, France|Hôpital de La Croix Rousse, Lyon, France|Hotel Dieu - Nantes, Nantes, France|Hopital de la Pitie Salpetriere, Paris, France|HOPITAL COCHIN university hospital, Paris, France|CHRU de Tours, Pharmacie, Tours, France|Universitatsklinikum Dusseldorf, Dusseldorf, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Uniklinik Köln, Köln, Germany|LMU Klinikum der Universitat Munchen, Munchen, Germany|Azienda Ospedaliera Dei Colli, Napoli, Campania, Italy|Istituto Nazionale Malattie Infettive Lazzaro Spallanzani IRCCS, Roma, Lazio, Italy|ASST Papa Giovanni XXIII; Dipartimento Interaziendale di Farmacia Clinica, Bergamo, Lombardia, Italy|ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milano, Lombardia, Italy|Azienda Ospedaliera San Gerardo di Monza, Monza MI, Lombardia, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria, Pavia, Lombardia, Italy|Amphia Ziekenhuis, Breda, Netherlands|St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, Netherlands|Erasmus MC, Rotterdam, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, Netherlands|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Spain|Greater Glasgow and Clyde Health Board, Glasgow, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|University College Hospital, London, United Kingdom|Royal Free Hospital, London, United Kingdom|St George's Clinical Research Facility, London, United Kingdom|Imperial College London, London, United Kingdom|North Manchester General Hospital, Manchester, United Kingdom|Salford Royal Hospital, Salford, United Kingdom"	"https://ClinicalTrials.gov/show/NCT04320615"
"287"	287	"NCT04372186"	"A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia"	"Recruiting"	"No Results Available"	"COVID-19 Pneumonia"	"drug: placebo|drug: tocilizumab"	"Phase 3"	"Interventional"	"Banner - University Medical Center Phoenix; In-Patient Pharmacy, Phoenix, Arizona, United States|Univ of AZ Coll of Med, Tucson, Arizona, United States|Scripps Mercy Hospital, Chula Vista, California, United States|El Centro Regional Medical Center, El Centro, California, United States|Harper University Hospital, Fountain Valley, California, United States|eStudySite, La Mesa, California, United States|Riverside University Health System-Medical Center, Moreno Valley, California, United States|Highland Hospital Oakland, Oakland, California, United States|St. Joseph'S Hospital, Orange, California, United States|Desert Regional Medical Center, Palm Springs, California, United States|San Leandro Hospital; Inpatient Pharmacy, San Leandro, California, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Greeley Hospital, Greeley, Colorado, United States|Medical Center of The Rockies, Loveland, Colorado, United States|Yale University School Of Medicine, New Haven, Connecticut, United States|Howard University, Washington, District of Columbia, United States|Suncoast Research Associates LLC - ERN - PPDS, Doral, Florida, United States|Miami Veterans Administration Healthcare System - NAVREF, Miami, Florida, United States|University of Miami Pulmonary, Miami, Florida, United States|Westchester General Hospital, Miami, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Columbus Regional Research Institute, Columbus, Georgia, United States|St. Lukes Boise Medical Center, Boise, Idaho, United States|Uni of Kansas Medical Center, Kansas City, Kansas, United States|Ochsner Clinic, New Orleans, Louisiana, United States|LSU-Shreveport, Shreveport, Louisiana, United States|Holy Cross Germantown Hospital, Germantown, Maryland, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Detroit Receiving Hospital, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Sinai Grace Hospital, Detroit, Michigan, United States|Optum Health Care, Las Vegas, Nevada, United States|St. Joseph'S Regional Medical Center, Paterson, New Jersey, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|St. Barnabas Hospital, Bronx, New York, United States|Kings County Hospital Center, Brooklyn, New York, United States|SUNY Downstate Medical Center., Brooklyn, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Flushing Hospital, Flushing, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|NYC Health and Hospitals Queens, Jamaica, New York, United States|Harlem Hospital, New York, New York, United States|Canton-Potsdam Hospital, Potsdam, New York, United States|Novant Health Presbyterian Medical Center (Presbyterian Hospital), Charlotte, North Carolina, United States|Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Novant Health Rowan Medical Center, Salisbury, North Carolina, United States|Novant Health Foryth Medical Center, Winston-Salem, North Carolina, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Sanford Health System, Sioux Falls, South Dakota, United States|JPS Health Network, Fort Worth, Texas, United States|Valley Baptist Medical Center, Harlingen, Texas, United States|Michael E Debakey VA Medical Center, Houston, Texas, United States|McAllen Medical Center, McAllen, Texas, United States|Crossroads Clinical Research, LLC, Victoria, Texas, United States|Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Aga Khan University Hospital, Nairobi, Kenya|Organismo Publico Descentralizado Hospital Juarez de Mexico, Ciudad De México, Mexico|Hospital General de Culiacan, Culiacan, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico|Hospital Militar Central, Jesus Maria, Peru|Hospital Nacional Dos de Mayo, Lima, Peru|University of the Free State, Bloemfontein, South Africa|George Provincial Hospital, George, South Africa|Mzansi Ethical Research Centre, Middelburg, South Africa|Milpark Hospital, Parktown West, South Africa|University of Stellenbosch; Respiratory Research, Parow, South Africa|Phoenix Pharma, Port Elizabeth, South Africa"	"https://ClinicalTrials.gov/show/NCT04372186"
"298"	298	"NCT04409262"	"A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia"	"Recruiting"	"No Results Available"	"COVID-19 Pneumonia"	"drug: remdesivir|drug: tocilizumab|drug: placebo"	"Phase 3"	"Interventional"	"Valleywise Health Medical Center, Phoenix, Arizona, United States|eStudySite - Chula Vista - PPDS, Chula Vista, California, United States|Hoag Hospital Irvine, Irvine, California, United States|Providence St. John's Health Center, Santa Monica, California, United States|Holy Cross Hospital Inc, Fort Lauderdale, Florida, United States|University of Miami Miller School of Medicine; Clinical Reseach Building, Miami, Florida, United States|St Luke's Health System; Rheumatology Research, Boise, Idaho, United States|Rush University Medical Center, Chicago, Illinois, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center/Ochsner, Shreveport, Louisiana, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|St. Michael'S Medical Center, Newark, New Jersey, United States|Wyckoff Heights Medical Center, Staten Island, New York, United States|Novant Health Clinical Research, Charlotte, North Carolina, United States|Cone Health Medical Group, Greensboro, North Carolina, United States|OhioHealth Research Institute, Columbus, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Allegheny Health Network (Pittsburg PA), Pittsburgh, Pennsylvania, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Intermountain LDS Hospital, Salt Lake City, Utah, United States|The Providence Regional Medical Center Everett, Everett, Washington, United States|West Virginia University Hospital, Morgantown, West Virginia, United States|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, MG, Brazil|Instituto de Pesquisa Clinica Evandro Chagas - IPEC FIOCRUZ, Rio de Janeiro, RJ, Brazil|Faculdade de Medicina do ABC - FMABC, Santo Andre, SP, Brazil|Instituto de Infectologia Emilio Ribas, Sao Paulo, SP, Brazil|Instituto do Coração - HCFMUSP, Sao Paulo, SP, Brazil"	"https://ClinicalTrials.gov/show/NCT04409262"
"431"	431	"NCT04377750"	"The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation"	"Recruiting"	"No Results Available"	"Covid19 Pneumonia"	"drug: tocilizumab"	"Phase 4"	"Interventional"	"Hadassah Medical Orginisation, Jerusalem, Please Select:, Israel|Barzilai Medical Center, Ashkelon, Israel|Wolfson Medical Center, H̱olon, Israel|Sheba Medical Center, Ramat Gan, Israel"	"https://ClinicalTrials.gov/show/NCT04377750"
"438"	438	"NCT04412291"	"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study"	"Recruiting"	"No Results Available"	"Covid-19"	"drug: anakinra prefilled syringe|drug: tocilizumab prefilled syringe|drug: standard-of-care treatment"	"Phase 2"	"Interventional"	"Karolinska University Hospital, Huddinge, Stockholm, Sweden"	"https://ClinicalTrials.gov/show/NCT04412291"
"448"	448	"NCT04335305"	"Checkpoint Blockade in COVID-19 Pandemic"	"Recruiting"	"No Results Available"	"COVID-19|Pneumonia, Viral"	"drug: tocilizumab|biological: pembrolizumab (mk-3475)"	"Phase 2"	"Interventional"	"Hospital Quirónsalud Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Ruber Juan Bravo, Madrid, Spain|Hospital Ruber Internacional, Madrid, Spain|Hospital Arnau de Vilanova-Lliria, Valencia, Spain|Hospital Universitario Doctor Peset, Valencia, Spain"	"https://ClinicalTrials.gov/show/NCT04335305"
"485"	485	"NCT04435717"	"Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01)"	"Recruiting"	"No Results Available"	"Covid19"	"drug: tocilizumab 20 mg/ml intravenous solution [actemra]_#1|drug: tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses)"	"Phase 2"	"Interventional"	"Hospital Universitario Ramón y Cajal, Madrid, Spain"	"https://ClinicalTrials.gov/show/NCT04435717"
"615"	615	"NCT04335071"	"Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)"	"Recruiting"	"No Results Available"	"SARS-CoV-2 Infection"	"drug: tocilizumab (tcz)|drug: placebo"	"Phase 2"	"Interventional"	"University Hospital Bern (Inselspital), Bern, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|Ospedale Regionale di Lugano (EOC), Viganello, Switzerland|University Hospital Zurich, Zurich, Switzerland"	"https://ClinicalTrials.gov/show/NCT04335071"
"634"	634	"NCT04424056"	"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease"	"Not yet recruiting"	"No Results Available"	"Covid19"	"drug: anakinra +/- ruxolitinib (stages 2b/3)|drug: anakinra and ruxolitinib (advanced stage 3)|drug: tocilizumab +/- ruxolitinib (stages 2b/3)|drug: tocilizumab and ruxolitinib (advanced stage 3)|other: standard of care"	"Phase 3"	"Interventional"	"Assistance Publique Hôpitaux de Marseille, Marseille, France"	"https://ClinicalTrials.gov/show/NCT04424056"
"639"	639	"NCT04377503"	"Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19"	"Not yet recruiting"	"No Results Available"	"Cytokine Release Syndrome|Covid-19"	"drug: tocilizumab 180 mg/ml|drug: methylprednisolone sodium succinate"	"Phase 2"	"Interventional"	""	"https://ClinicalTrials.gov/show/NCT04377503"
"647"	647	"NCT04349410"	"The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol"	"Enrolling by invitation"	"No Results Available"	"CoVid 19 Positive"	"drug: hydroxychloroquine, azithromycin|drug: hydroxychloroquine, doxycycline|drug: hydroxychloroquine, clindamycin|drug: hydroxychloroquine, clindamycin, primaquine - low dose.|drug: hydroxychloroquine, clindamycin, primaquine - high dose.|drug: remdesivir|drug: tocilizumab|drug: methylprednisolone|drug: interferon-alpha2b|drug: losartan|drug: convalescent serum"	"Phase 2|Phase 3"	"Interventional"	"FHHI-OI-Camelot; QME, Los Angeles, California, United States"	"https://ClinicalTrials.gov/show/NCT04349410"
"665"	665	"NCT04363853"	"Tocilizumab Treatment in Patients With COVID-19"	"Recruiting"	"No Results Available"	"Sars-CoV2"	"drug: tocilizumab"	"Phase 2"	"Interventional"	"National Cancer Institute of Mexico, Mexico city, Distrito Federal, Mexico"	"https://ClinicalTrials.gov/show/NCT04363853"
"674"	674	"NCT04356937"	"Efficacy of Tocilizumab on Patients With COVID-19"	"Recruiting"	"No Results Available"	"SARS-CoV 2"	"drug: tocilizumab|drug: placebos"	"Phase 3"	"Interventional"	"Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States"	"https://ClinicalTrials.gov/show/NCT04356937"
"676"	676	"NCT04361032"	"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia"	"Not yet recruiting"	"No Results Available"	"COVID19|Intensive Care Unit"	"drug: tocilizumab injection|drug: deferoxamine"	"Phase 3"	"Interventional"	"Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Ariana, Ariana, Tunisia"	"https://ClinicalTrials.gov/show/NCT04361032"
"719"	719	"NCT04333914"	"Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection"	"Suspended"	"No Results Available"	"SARS-CoV-2 (COVID-19) Infection|Advanced or Metastatic Hematological or Solid Tumor"	"drug: chloroquine analog (gns651)|drug: nivolumab|drug: tocilizumab|other: standard of care|drug: avdoralimab|drug: monalizumab"	"Phase 2"	"Interventional"	"Centre Léon Bérard, Lyon, Rhône, France|CHU Clermont Ferrand, Clermont Ferrand, France|Centre Oscar Lambret, Lille, France|AP-HP Hôpital Saint Antoine, Paris, France|AP-HP La Pitié Salpétrière, Paris, France|Hôpital Saint-Joseph, Paris, France|AP-HP Tenon, Paris, France|AP-HP Hôpital Bichat Claude Bernard, Paris, France|GH Diaconesses Croix Saint Simon, Paris, France|Gustave Roussy, Villejuif, France"	"https://ClinicalTrials.gov/show/NCT04333914"
"743"	743	"NCT04339712"	"Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction"	"Recruiting"	"No Results Available"	"COVID-19|Virus Diseases|Macrophage Activation Syndrome|Corona Virus Infection"	"drug: anakinra|drug: tocilizumab"	"Phase 2"	"Interventional"	"2nd Department of Critical Care Medicine, ATTIKON University Hospital, Athens, Haidari, Greece|Intensive Care Unit, Ioannina University Hospital, Ioánnina, Ioannina, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Rion, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|Intensive Care Unit, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Pulmonary Medicine and Intensive Care Unit, Athens, Greece|Intensive Care Unit, General Hospital of Athens IPPOKRATEIO, Athens, Greece|4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece|Intensive Care Unit, General Hospital ASKLEPIEIO Voulas, Athens, Greece|Intensive Care Unit, \"Latsio\", Thriasio Elefsis General Hospital, Elefsína, Greece|Intensive Care Unit, \"Koutlimbaneio & Triantafylleio\" Larissa General Hospital, Larissa, Greece|Department of Internal Medicine, Larissa University Hospital, Larissa, Greece|Intensive Care Unit, AGIOS DIMITRIOS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, G. GENNIMATAS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, General Hospital of Thessaloniki IPPOKRATEIO, Thessaloniki, Greece|Department of Anesthesiology and Intensive Care Medicine, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece"	"https://ClinicalTrials.gov/show/NCT04339712"
"807"	807	"NCT04310228"	"Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019"	"Recruiting"	"No Results Available"	"COVID-19"	"drug: favipiravir combined with tocilizumab|drug: favipiravir|drug: tocilizumab"	"Not Applicable"	"Interventional"	"Guiqiang Wang, Beijing, Beijing, China|Peking University First Hospital, Beijing, Beijing, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China"	"https://ClinicalTrials.gov/show/NCT04310228"
"912"	912	"NCT04381936"	"Randomised Evaluation of COVID-19 Therapy"	"Recruiting"	"No Results Available"	"Severe Acute Respiratory Syndrome"	"drug: lopinavir-ritonavir|drug: corticosteroid|drug: hydroxychloroquine|drug: azithromycin|biological: convalescent plasma|drug: tocilizumab"	"Phase 2|Phase 3"	"Interventional"	"Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom"	"https://ClinicalTrials.gov/show/NCT04381936"
"934"	934	"NCT04370834"	"Tocilizumab for Patients With Cancer and COVID-19 Disease"	"Recruiting"	"No Results Available"	"Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Pneumonia|Pneumonitis|Severe Acute Respiratory Distress Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed"	"biological: tocilizumab"	"Phase 2"	"Interventional"	"National Cancer Institute, Rockville, Maryland, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Valley Medical Center, Renton, Washington, United States"	"https://ClinicalTrials.gov/show/NCT04370834"
"973"	973	"NCT04380818"	"Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19"	"Recruiting"	"No Results Available"	"Pneumonia, Viral"	"radiation: low-dose radiotherapy|drug: hydroxychloroquine sulfate|drug: ritonavir/lopinavir|drug: tocilizumab injection [actemra]|drug: azithromycin|drug: corticosteroid|drug: low molecular weight heparin|device: oxygen supply"	"Not Applicable"	"Interventional"	"Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, Spain"	"https://ClinicalTrials.gov/show/NCT04380818"
"980"	980	"NCT02735707"	"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia"	"Recruiting"	"No Results Available"	"Community-acquired Pneumonia, Influenza, COVID-19"	"drug: fixed-duration hydrocortisone|drug: shock-dependent hydrocortisone|drug: ceftriaxone|drug: moxifloxacin or levofloxacin|drug: piperacillin-tazobactam|drug: ceftaroline|drug: amoxicillin-clavulanate|drug: macrolide administered for 3-5 days|drug: macrolide administered for up to 14 days|drug: five-days oseltamivir|drug: ten-days oseltamivir|drug: lopinavir/ritonavir|drug: hydroxychloroquine|drug: hydroxychloroquine + lopinavir/ritonavir|drug: interferon-β1a|drug: anakinra|drug: fixed-duration higher dose hydrocortisone|drug: tocilizumab|drug: sarilumab"	"Phase 4"	"Interventional"	"St Vincent's Hospital Sydney, Sydney, New South Wales, Australia|Royal Prince Alfred Hospital, Sydney, New South Wales, Australia|Royal North Shore Hospital, Sydney, New South Wales, Australia|Nepean Hospital, Sydney, New South Wales, Australia|Wollongong Hospital, Sydney, New South Wales, Australia|Royal Darwin Hospital,, Darwin, Northern Territory, Australia|Sunshine Coast University Hospital, Birtinya, Queensland, Australia|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Logan Hospital, Brisbane, Queensland, Australia|Toowoomba Hospital, Toowoomba, Queensland, Australia|The Queen Elizabeth Hospital, Adelaide, South Australia, Australia|Bendigo Hospital, Bendigo, Victoria, Australia|University Hosptial Geelong, Geelong, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Melbourne, Victoria, Australia|St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|Sir Charles Gairdner Hospital, Perth, Western Australia, Australia|St John of God Hospital Midland, Perth, Western Australia, Australia|Fiona Stanley Hospital, Perth, Western Australia, Australia|St John of God Hospital Murdoch, Perth, Western Australia, Australia|AZ Sint-Jan, Brugge, Belgium|CHU de Charleroi - Hôpital Civil Marie Curie, Charleroi, Belgium|Universitair Ziekenhuis Antwerp, Edegem, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|St. Joseph's Healthcare Hamilton, Hamilton, Canada|Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke, Canada|St. Michael's Hospital Unity Health Toronto, Toronto, Canada|General County Hospital Požega, Požega, Croatia|University Hospital Centre Zagreb, Zagreb, Croatia|University Hospital for Infectious Diseases, Zagreb, Croatia|Charité - Universitätsmedizin Berlin - Infektiologie und Pneumologie, Berlin, Germany|Charité - Universitätsmedizin Berlin - Nephrologie, Berlin, Germany|Vivantes Klinikum Neukölln, Berlin, Germany|Universitätsklinikum Köln, Cologne, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Jena, Jena, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|Universitäts Klinikum Tübingen, Tübingen, Germany|Universitätsklinikum Würzburg, Würzburg, Germany|Jósa András County Hospital, Nyíregyháza, Hungary|Csolnoky Ferenc Kórház - Veszprem County Hospital, Veszprém, Hungary|Almási Balogh Pál Kórház, Ózd, Hungary|Beaumont Hospital, Dublin, Ireland|St. Vincent's University Hospital, Dublin, Ireland|University Hospital Galway, Galway, Ireland|Meander Medisch Centrum, Amersfoort, Netherlands|Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands|Martini Hospital Groningen, Groningen, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|North Shore Hospital, Auckland, New Zealand|CVICU, Auckland City Hospital, Auckland, New Zealand|DCCM, Auckland City Hospital, Auckland, New Zealand|Middlemore Hospital, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|Waikato Hospital, Hamilton, New Zealand|Rotorua Hospital, Rotorua, New Zealand|Tauranga Hospital, Tauranga, New Zealand|Wellington Regional Hospital, Wellington, New Zealand|Whangarei Hospital, Whangarei, New Zealand|Centro Hospitalar do Medio Tejo, Abrantes, Portugal|Hospital Lusíadas Lisbon, Lisboa, Portugal|Clinical Hospital of Infectious and Tropical Diseases \"Dr. Victor Babes\", Bucharest, Romania|Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain|Hospital Universitario Reina Sofia, Córdoba, Spain|Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom|Southmead Hospital, Bristol, United Kingdom|University Hospital Coventry, Coventry, United Kingdom|Darlington Memorial Hospital, Darlington, United Kingdom|University Hospital of North Durham, Durham, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|Maidstone Hospital - Maidstone and Tunbridge Wells NHS Trust, Maidstone, United Kingdom|The James Cook University Hospital, Middlesbrough, United Kingdom|Milton Keynes University Hospital, Milton Keynes, United Kingdom|Northampton General Hospital, Northampton, United Kingdom|Queen's Medical Centre - Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Poole Hospital NHS Foundation Trust, Poole, United Kingdom|Queen Alexandra Hospital - Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom|Royal Berkshire Hospital, Reading, United Kingdom|University Hospital of North Tees, Stockton-on-Tees, United Kingdom|Royal Cornwall Hospital, Truro, United Kingdom|Tunbridge Wells Hospital - Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, United Kingdom|York Hospital, York, United Kingdom"	"https://ClinicalTrials.gov/show/NCT02735707"
"1000"	1000	"NCT04394182"	"Ultra Low Doses of Therapy With Radiation Applicated to COVID-19"	"Recruiting"	"No Results Available"	"Pneumonia, Viral|Cytokine Storm"	"radiation: ultra-low-dose radiotherapy|device: ventilatory support with oxygen therapy|drug: lopinavir/ritonavir|drug: hydroxychloroquine|drug: azithromycin|drug: piperacillin/tazobactam|drug: low molecular weight heparin|drug: corticosteroid injection|drug: tocilizumab"	"Not Applicable"	"Interventional"	"Hospital La Milagrosa, GenesisCare, Madrid, Spain|Hospital Vithas Valencia Consuelo, Valencia, Spain"	"https://ClinicalTrials.gov/show/NCT04394182"
"1058"	1058	"NCT04403685"	"Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers"	"Recruiting"	"No Results Available"	"COVID|SARS Pneumonia|Cytokine Release Syndrome"	"drug: tocilizumab"	"Phase 3"	"Interventional"	"UNIFESP, São Paulo, Sao Paulo, Brazil|HCOR -Hospital do Coracao, Sao Paulo, SP, Brazil|HAOC - Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil|Beneficência Portuguesa de Sao Paulo, Sao Paulo, Brazil|HAOC - Hospital Alemao Oswaldo Cruz - unidade Vergueiro, Sao Paulo, Brazil|HIAE - Hospital Israelita Albert Einstein, Sao Paulo, Brazil|HSL - Hospital Sírio Libanês, Sao Paulo, Brazil"	"https://ClinicalTrials.gov/show/NCT04403685"
"1105"	1105	"NCT04315480"	"Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis"	"Active, not recruiting"	"No Results Available"	"SARS Pneumonia"	"drug: tocilizumab"	"Phase 2"	"Interventional"	"Università Politecnica delle Marche, Ancona, AN, Italy"	"https://ClinicalTrials.gov/show/NCT04315480"
"1229"	1229	"NCT04361552"	"Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)"	"Withdrawn"	"No Results Available"	"Cerebrovascular Accident|Chronic Obstructive Pulmonary Disease|Chronic Renal Failure|Coronary Artery Disease|Diabetes Mellitus|Malignant Neoplasm|SARS Coronavirus 2 Infection"	"other: best practice|biological: tocilizumab"	"Phase 3"	"Interventional"	"Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States"	"https://ClinicalTrials.gov/show/NCT04361552"
"1259"	1259	"NCT04347031"	"A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19"	"Active, not recruiting"	"No Results Available"	"Pneumonia, Viral|Respiratory Failure"	"drug: mefloquine|drug: hydroxychloroquine|combination product: mefloquine + azithromycin + / - tocilizumab|combination product: hydroxychloroquine + azithromycin + / - tocilizumab"	"Phase 2|Phase 3"	"Interventional"	"Burnasyan Federal Medical Biophysical Center FMBA of Russia, Moscow, Russian Federation"	"https://ClinicalTrials.gov/show/NCT04347031"
"1272"	1272	"NCT04423042"	"Tocilizumab in Coronavirus-19 Positive Patients"	"Not yet recruiting"	"No Results Available"	"Covid19|COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Coronavirus|Inflammation"	"biological: tocilizumab"	"Phase 3"	"Interventional"	""	"https://ClinicalTrials.gov/show/NCT04423042"
"1320"	1320	"NCT04331808"	"CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)"	"Active, not recruiting"	"No Results Available"	"Corona Virus Infection"	"drug: tocilizumab"	"Phase 2"	"Interventional"	"APHP- Hopital Tenon, Paris, France|APHP - Beaujon, Paris, France|APHP - Bichat, Paris, France|APHP - Hopital Necker, Paris, France|APHP - Pitié Salpêtrière, Paris, France|APHP - Saint Louis, Paris, France|CHU Strasbourg, Strasbourg, France|Institut Gustave Roussy, Villejuif, France"	"https://ClinicalTrials.gov/show/NCT04331808"
